{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:28:41Z","timestamp":1787635721539,"version":"build-2736575974"},"reference-count":6,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.psym.2020.04.006","type":"journal-article","created":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T02:02:39Z","timestamp":1587175359000},"page":"861-863","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Concerns Regarding the Use of Phenobarbital for Alcohol Withdrawal Management"],"prefix":"10.1016","volume":"61","author":[{"given":"Mohammadreza","family":"Azadfard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Danzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psym.2020.04.006_bib1","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.psym.2019.02.002","article-title":"Use of phenobarbital in alcohol withdrawal management - a retrospective comparison study of phenobarbital and benzodiazepines for acute alcohol withdrawal management in general medical patients","volume":"60","author":"Nisavic","year":"2019","journal-title":"Psychosomatics"},{"key":"10.1016\/j.psym.2020.04.006_bib2","first-page":"38","article-title":"Treatment of alcohol withdrawal","volume":"22","author":"Myrick","year":"1998","journal-title":"Alcohol Health Res World"},{"key":"10.1016\/j.psym.2020.04.006_bib3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/WNF.0000000000000172","article-title":"Therapeutic index estimation of antiepileptic drugs: a systematic literature review approach","volume":"39","author":"Greenberg","year":"2016","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.psym.2020.04.006_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/j.1875-9114.1996.tb02915.x","article-title":"Benzodiazepines for alcohol withdrawal in the elderly and in patients with liver disease","volume":"16","author":"Peppers","year":"1996","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.psym.2020.04.006_bib5","doi-asserted-by":"crossref","first-page":"224","DOI":"10.11124\/jbisrir-2015-1602","article-title":"The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review","volume":"13","author":"Woods","year":"2015","journal-title":"JBI Database System Rev Implement Rep"},{"key":"10.1016\/j.psym.2020.04.006_bib6","doi-asserted-by":"crossref","first-page":"e768","DOI":"10.1097\/CCM.0000000000003204","article-title":"Adjunct ketamine use in the management of severe ethanol withdrawal","volume":"46","author":"Pizon","year":"2018","journal-title":"Crit Care Med"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318220301171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318220301171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:29:11Z","timestamp":1758500951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318220301171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0033318220301171"],"URL":"https:\/\/doi.org\/10.1016\/j.psym.2020.04.006","relation":{},"ISSN":["0033-3182"],"issn-type":[{"value":"0033-3182","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Concerns Regarding the Use of Phenobarbital for Alcohol Withdrawal Management","name":"articletitle","label":"Article Title"},{"value":"Psychosomatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psym.2020.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of Academy of Consultation-Liaison Psychiatry.","name":"copyright","label":"Copyright"}]}}